PDS Biotech Announces Initial $11.3M PIPE Closing and Board Appointment
PDS Biotechnology closed an initial $11.3 million financing round led by Nant Capital and appointed Dr. Patrick Soon-Shiong to its board, using proceeds to repay debt, fund working capital, and advance the PDS0301 immunotherapy.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day